共 14 条
[1]
Biochemical detection of left -ventricular dysfunction in systolic dysfunction. McDonagh T,Robb SD,Murdoch DR,et al. The Lancet . 1998
[2]
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Cowie MR,Struthers AD,Wood DA,et al. The Lancet . 1997
[3]
Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans. Clerico A,Lervasi G,Mariani G. Hormone and Metabolic Research . 1999
[4]
Risk Stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Ishii J,Nomura M,Nakamura Y,et al. The American Journal of Cardiology . 2002
[5]
Effect of Beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor. Hara Y,Hamada M,Shigematsu Y,et al. Japanese Circulation Journal . 2000
[6]
Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Morita E,Yasue H,Yoshimura M,et al. Circulation . 1993
[7]
Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Maisel AS,Koon J,Krishnaswamy P,et al. American Heart Journal . 2001
[8]
Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Luchner A,Brokel U,Muscholl M,et al. Cardiovascular Research . 2002
[9]
Utility of B-Natriuretic peptide in detecting diastolic dysfunction. Lubien E,DeMaria A,Krishnaswamy P,et al. Circulation . 2002
[10]
A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma.Reference values in healthy subjects and in patients with different diseases. Jensen KT,Carstens J,Ivarsen P,et al. Scandinavian Journal of Clinical and Laboratory Investigation . 1997